Article
Identification of potential inhibitors for HCV NS5b of genotype 4a by combining dynamic simulation, protein-ligand interaction fingerprint, 3D pharmacophore, docking and 3D QSAR.
Journal of biomolecular structure & dynamics - 1 Sept 2020
El-Hassab Mahmoud Abd El-Monem, El-Bastawissy Eman Esmat, El-Moselhy Tarek Fathy
Abstract excerpt
HCV NS5B polymerase has been one of the most attractive targets for developing new drugs for HCV infection and many drugs were successfully developed, but all of them were designed for targeting Hepatitis C Virus genotype 1 (HCV GT1). Hepatitis C virus genotype 4a (HCV GT4a) dominant in Egypt has paid less attention. Here, we describe our protocol of virtual screening in identification of novel potential potent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.